IG 257
Pill imprint IG 257 has been identified as Nabumetone 500 mg.
Nabumetone is used in the treatment of rheumatoid arthritis; osteoarthritis; back pain; muscle pain; sciatica (and more), and belongs to the drug class nonsteroidal anti-inflammatory agents. Risk cannot be ruled out during pregnancy.
Nabumetone 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Nabumetone Images
- Imprint:
-
IG
257 - Strength:
- 500 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
hypromellose
sodium lauryl sulfate
silicon dioxide
magnesium stearate
titanium dioxide
polyethylene glycol
polysorbate 80
- Drug Class:
- Nonsteroidal anti-inflammatory agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Glenmark Generics Inc.
- National Drug Code (NDC):
- 68462-0358
| NDC Code | Manufacturer / Repackager |
|---|---|
| 49884-0195 | Par Pharmaceutical |
Note: Inactive ingredients may vary.
More Nabumetone resources
- Nabumetone (Wolters Kluwer)
- nabumetone (Cerner Multum)
- nabumetone (Micromedex) - Includes Dosage Information
- Nabumetone (AHFS DI)
- Nabumetone (FDA)
- Nabumetone (Wolters Kluwer)


